0.6372
전일 마감가:
$0.6537
열려 있는:
$0.667
하루 거래량:
67,829
Relative Volume:
0.01
시가총액:
$9.51M
수익:
-
순이익/손실:
$-53.12M
주가수익비율:
-0.00586
EPS:
-108.8
순현금흐름:
$-15.86M
1주 성능:
+14.63%
1개월 성능:
+3.26%
6개월 성능:
-87.93%
1년 성능:
-90.47%
블루 워터 백신 Stock (ONCO) Company Profile
명칭
Onconetix Inc
전화
513-620-4101
주소
201 E. FIFTH STREET, CINCINNATI
ONCO을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ONCO
Onconetix Inc
|
0.6373 | 9.51M | 0 | -53.12M | -15.86M | -108.80 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
477.83 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
725.48 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
656.16 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
274.75 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
![]()
BNTX
Biontech Se Adr
|
119.16 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
블루 워터 백신 주식(ONCO)의 최신 뉴스
Investing in Onconetix Inc (ONCO) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Onconetix Inc (ONCO) Stock: A Year of Decreases and Increases - The InvestChronicle
Daily Market Movement: Onconetix Inc (ONCO) Sees a 11.91 Increase, Closing at 0.61 - The Dwinnex
Onconetix files to sell 50M shares of common stock for holders - MSN
Stock market today: Allakos dropped by 76.37% whereas Onconetix jumped by 77.10% in early trading - Business Upturn
Onconetix faces Nasdaq delisting over share price rule - MSN
Onconetix faces Nasdaq delisting over share price rule By Investing.com - Investing.com Nigeria
Onconetix settles with IQVIA, adjusts accounts payable - MSN
Onconetix settles with IQVIA, adjusts accounts payable By Investing.com - Investing.com Canada
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet - Benzinga
ONCO Stock Plummets to 52-Week Low at $0.37 Amid Market Struggles By Investing.com - Investing.com South Africa
Onconetix files overdue quarterly report, addresses Nasdaq notice By Investing.com - Investing.com South Africa
Onconetix files overdue quarterly report, addresses Nasdaq notice - Investing.com
Onconetix, Inc. Announces Receipt of Notice from Nasdaq - GlobeNewswire
Onconetix Resolves Nasdaq Compliance Issue After Late Q3 Filing - StockTitan
ONCO stock touches 52-week low at $0.58 amid market challenges - Investing.com India
Onconetix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Onconetix Inc. (ONCO) reports earnings - Quartz
Onconetix amends forbearance agreement with Veru Inc. - Investing.com
ONCO Stock Hits 52-Week Low at $0.6 Amid Market Challenges - Investing.com Nigeria
ONCO stock touches 52-week low at $0.99 amid market challenges By Investing.com - Investing.com South Africa
ONCO stock touches 52-week low at $0.99 amid market challenges - Investing.com
SEC Form 424B4 filed by Onconetix Inc. - Quantisnow
Zurcher Kantonalbank's Strategic Acquisition of Onconetix Inc Sh - GuruFocus.com
ONCO stock touches 52-week low at $2.8 amid market challenges By Investing.com - Investing.com South Africa
ONCO stock touches 52-week low at $2.8 amid market challenges - Investing.com Canada
Onconetix, Inc. (NASDAQ:ONCO) Sees Large Decline in Short Interest - MarketBeat
Onconetix announces change in certifying accountant - Investing.com India
Onconetix announces change in certifying accountant By Investing.com - Investing.com South Africa
Onconetix, Inc. (NASDAQ:ONCO) Short Interest Update - MarketBeat
Onconetix announces financing through $2M private placement - TipRanks
Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C - The Bakersfield Californian
Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit - GlobeNewswire
Onconetix raises $2 million in private placement - Investing.com
Onconetix Secures Funding to Enhance Operations and Growth - TipRanks
Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit - GlobeNewswire
Onconetix Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
What's Going On With Onconetix Shares Friday? - MSN
Investing in Onconetix Inc (ONCO) might be a great opportunity, but the stock is a bit overvalued - US Post News
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.20% - MSN
블루 워터 백신 (ONCO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):